- Investing Ideas
- /
- Global Small Cap High Growth Stocks
Global Small Cap High Growth Stocks
Results
2178
0 new
Companies below a US$500M market cap with strong earnings growth forecasted for the next 3 years.
2,178 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
A253590 | ₩11,280.00 | -0.9% | 198.4% | ₩479.4b | n/a | PE86.1x | E71.3% | 0.3% | Semiconductors | ||
9218 | JP¥800.00 | 1.9% | -0.7% | JP¥8.3b | n/a | PE101.9x | E79.6% | n/a | Healthcare | ||
YGG | ฿0.91 | -5.2% | -86.8% | ฿547.8m | ฿10.75 | PS1.9x | E85.5% | 29.5% | Media | ||
3DA | AU$0.40 | -2.4% | 48.1% | AU$239.8m | n/a | PS517.1x | E59.4% | n/a | Capital Goods | ||
A067310 | ₩11,400.00 | -5.7% | -48.2% | ₩687.3b | ₩21,898.55 | PB2.4x | E100.3% | 0.4% | Semiconductors | ||
AFISH | NOK 49.00 | 0% | -44.3% | NOK 1.6b | NOK 81.00 | PS1.6x | E98.9% | n/a | Food, Beverage & Tobacco | ||
SCOL | SEK 0.14 | -11.1% | -91.4% | SEK 31.5m | n/a | PB0.7x | E75.3% | n/a | Pharmaceuticals & Biotech | ||
MX1 | AU$0.06 | -14.3% | -53.8% | AU$34.9m | n/a | PS2.3x | E86.1% | n/a | Healthcare | ||
MBTN | CHF 1.60 | -7.8% | -99.2% | CHF 49.2m | CHF 6.03 | PB0.3x | E95.4% | n/a | Semiconductors | ||
CUV | AU$14.09 | -1.5% | -5.7% | AU$703.8m | AU$29.17 | PE19.7x | E27.4% | 0.4% | Pharmaceuticals & Biotech | ||
7373 | JP¥1,515.00 | -4.3% | -24.5% | JP¥23.2b | JP¥4,600.00 | PE22.9x | E32.7% | 2.0% | Commercial Services | ||
AV1 | AU$0.075 | -1.3% | 50.0% | AU$59.2m | n/a | PS14.2x | E144.2% | n/a | Software | ||
MVW | NOK 10.30 | 0% | 31.0% | NOK 337.0m | NOK 12.20 | PS19.6x | E70.8% | n/a | Materials | ||
ICOP | €6.90 | 10.9% | n/a | €190.7m | €9.30 | PE37.8x | E49.2% | n/a | Capital Goods | ||
7096 | JP¥1,669.00 | 0.7% | -30.7% | JP¥17.1b | n/a | PE41.4x | E38.4% | n/a | Healthcare | ||
NVG | zł1.83 | -0.3% | -22.3% | zł63.9m | zł3.65 | PE235.8x | E41.4% | 3.3% | Diversified Financials | ||
ZVRA | US$7.20 | 4.0% | 53.2% | US$378.8m | US$20.50 | PS16x | E68.5% | n/a | Pharmaceuticals & Biotech | ||
BBT | AU$0.23 | 7.1% | 4.7% | AU$127.3m | n/a | PS2.2x | E97.9% | n/a | Consumer Services | ||
NEWBRY | SEK 3.98 | 8.7% | 26.3% | SEK 96.5m | SEK 8.00 | PS5.2x | E116.2% | n/a | Pharmaceuticals & Biotech | ||
A179900 | ₩24,150.00 | 4.8% | -13.1% | ₩382.1b | ₩60,000.00 | PS19.1x | E134.6% | 0% | Tech | ||
LAVV3 | R$8.08 | 1.0% | 17.3% | R$1.6b | R$12.98 | PE5.8x | E21.1% | 3.5% | Real Estate Management and Development | ||
AGP | €7.11 | 1.9% | 43.3% | €123.1m | €12.85 | PE18.2x | E22.1% | n/a | Capital Goods | ||
RMDA | ج.م3.14 | 10.2% | 135.7% | ج.م4.7b | ج.م4.11 | PE20.8x | E30.2% | 2.1% | Pharmaceuticals & Biotech | ||
PLT | AU$0.71 | -8.3% | 104.3% | AU$125.4m | AU$1.30 | PS1.7x | E106.4% | n/a | Diversified Financials |